Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH)
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Kozminski MA, Wei JT, Nelson J, Kent DM. Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH). BJU Int. 2015 Feb;115(2):308-16. doi: 10.1111/bju.12802. Epub 2014 Aug 13. PubMed PMID: 24825577; PubMed Central PMCID: PMC4231026.
Tags
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study (with results)
- Other Results
Journal Publication Name
- BJU International
Literature Type
- PCORI Research